Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency

被引：1
|
作者：
Wasniewska, M. [1 ]
Valenzise, M. [1 ]
Aversa, T. [1 ]
Mirabelli, S. [1 ]
De Luca, F. [1 ]
De Luca, F. L. [1 ]
Lombardo, F. [1 ]
机构：
[1] Univ Messina, Dept Pediat, Messina, Italy
来源：
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2011年 / 34卷 / 02期
关键词：
CONGENITAL ADRENAL-HYPERPLASIA; BLOOD-PRESSURE; DEVELOPMENTAL EXPRESSION; ADOLESCENTS; CYP2C19;
D O I：
10.1007/BF03347048
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：159 / 161
页数：3
相关论文
共 50 条
  • [11] Salt-wasting 21-hydroxylase deficiency congenital adrenal hyperplasia and pyloric stenosis in two hispanic brothers
    Pitukcheewanont, Pisit
    Nimkarn, Saroj
    Austin, Juliana
    Sack, Zadok
    Fisher, Lynda K.
    JOURNAL OF PEDIATRICS, 2006, 149 (02): : 268 - 270
  • [12] Sexual ambiguity by salt-wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A case report
    Abarca-Acuna, Bryan
    Delgado-Valencia, Edison
    Atamari-Anahui, Noe
    Zea-Nunez, Carlos
    REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2015, 8 (01): : 25 - 27
  • [13] Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Gomes, Larissa G.
    Madureira, Guiomar
    Mendonca, Berenice B.
    Bachega, Tania A. S. S.
    CLINICS, 2013, 68 (02) : 147 - 151
  • [14] Novel intronic CYP21A2 mutation in a Japanese patient with classic salt-wasting steroid 21-hydroxylase deficiency
    Katsumata, Noriyuki
    Shinagawa, Takashi
    Horikawa, Reiko
    Fujikura, Kaori
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (11): : 1628 - 1632
  • [15] Exploring the growth curves of 248 Chinese patients aged 0-3 years with salt-wasting 21-hydroxylase deficiency
    Li, Yingying
    Fan, Xin
    Wang, Yirou
    Zhao, Xiu
    Pan, Lili
    Yu, Yuting
    Gong, Chunxiu Gong
    Su, Zhe
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 124 - 125
  • [16] The progression of salt-wasting and the body weight change during the first 2 weeks of life in classical 21-hydroxylase deficiency patients
    Gau, Maki
    Konishi, Kaoru
    Takasawa, Kei
    Nakagawa, Ryuichi
    Tsuji-Hosokawa, Atsumi
    Hashimoto, Atsuko
    Sutani, Akito
    Tajima, Toshihiro
    Hasegawa, Tomonobu
    Morio, Tomohiro
    Kashimada, Kenichi
    CLINICAL ENDOCRINOLOGY, 2021, 94 (02) : 229 - 236
  • [17] STEROID 21-HYDROXYLASE DEFICIENCY - 2 ADDITIONAL MUTATIONS IN SALT-WASTING DISEASE AND RAPID SCREENING OF DISEASE-CAUSING MUTATIONS
    WEDELL, A
    LUTHMAN, H
    HUMAN MOLECULAR GENETICS, 1993, 2 (05) : 499 - 504
  • [18] A novel mutation of the CYP21 gene detected in two Korean sisters with salt-wasting 21-hydroxylase deficiency congenital adrenal hyperplasia
    Jung, Min Ho
    Cho, Won Kyung
    Cho, Kyoung Soon
    Park, So Hyun
    Kim, Gu-Hwan
    Yoo, Han-Wook
    Suh, Byung Kyu
    Lee, Byung Churl
    HORMONE RESEARCH, 2008, 70 : 144 - 144
  • [19] Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: In early infancy and (pre)puberty
    Stikkelbroeck, NMML
    van't Hof-Grootenboer, BAE
    Hermus, ARMM
    Otten, BJ
    van't Hof, MA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08): : 3525 - 3530
  • [20] Mineralocorticoid replacement therapy in salt-wasting congenital adrenal hyperplasia
    Lang, Katharina
    Quinkler, Marcus
    Kienitz, Tina
    CLINICAL ENDOCRINOLOGY, 2024, 101 (04) : 346 - 358
12345